Industry News
American Society Of Clinical Oncology Issues Annual Report On Progress Against Cancer
Dec 06, 2011
The American Society of Clinical Oncology (ASCO) released Clinical Cancer Advances 2011: ASCO's Annual Report on Progress Against Cancer, an independent review of the advances in cancer research that have had the greatest impact on patient care this year... Read More
Neurotransmitter Might Improve The Treatment Of Cancer
Dec 06, 2011
Doses of a neurotransmitter might offer a way to boost the effectiveness of anticancer drugs and radiation therapy, according to a new study led by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute... Read More
Ovarian Cancer Outcome Can Be Predicted By Tiny Genetic Variation
Dec 06, 2011
Yale Cancer Center researchers have shown that a tiny genetic variation predicts chances of survival and response to treatment for patients with ovarian cancer. The findings, published in the journal Oncogene, provide new insights into the biology of a new class of cancer marker and suggest a genetic test may help guide the treatment of women with ovarian cancer... Read More
'Encouraging' Skin Cancer Discovery
Dec 06, 2011
SCIENTISTS in Glasgow have made an important discovery in the fight against malignant melanoma, the most dangerous form of skin cancer. Unlike most other cancers, malignant melanoma is disproportionately higher in younger people than in other age groups. More than two young adults (aged 15-34) in the UK are diagnosed with the disease every day... Read More
Making The 'Undruggable' Ras Oncogene 'Druggable'
Dec 06, 2011
A drug discovery team at Genentech, Inc., has uncovered a chink in the molecular armor of Ras, the most commonly occurring oncogene, which is a gene that when mutated has the potential of causing cancer in humans... Read More
New Reprogramming Mechanism For Tumor Cells Discovered
Dec 06, 2011
A study by researchers Raul Mendez, ICREA Research Professor at the Institute for Research in Biomedicine (IRB Barcelona) and Pilar Navarro at the IMIM (Institut de Recerca Hospital del Mar, Barcelona) describes a new reprogramming mechanism for the expression of genes responsible for turning a healthy cell into a tumor cell... Read More
Study Results On Frequent Mutation Of Genes Encoding UMPP Components In Kidney Cancer
Dec 06, 2011
BGI, the world's largest genomics organization, announced that a study on frequent mutation of genes encoding ubiquitin-mediated proteolysis pathway (UMPP) components in clear cell renal cell carcinoma (ccRCC) is published online in Nature Genetics. In addition to BGI, co-leaders of the study included Peking University Shenzhen Hospital, Shenzhen Second People's Hospital, among others... Read More
Gender Disparity In Skin-Cancer Rate May Be Explained By Antioxidant Levels
Dec 05, 2011
Men are three times more likely than women to develop a common form of skin cancer but medical science doesn't know why. A new study may provide part of the answer. Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J... Read More
Inflammatory Cues Modulate Goblet Cell Products Important For Intestinal Barrier Function
Dec 05, 2011
In a paper published in the December 2011 issue of Experimental Biology and Medicine, a team of scientists at the University of Illinois, Urbana-Champaign led by Rex Gaskins, PhD have demonstrated that both microbial and host inflammatory factors modulate sulfomucin production in a human cell line, LS174T, that models intestinal goblet cells... Read More
JCI Online Early Table Of Contents: Dec. 1, 2011
Dec 05, 2011
CARDIOLOGY: Unraveling the adverse effects of a blood pressure medication Drugs that block L-type Ca2+ channels (LTCCs) are widely used to treat high blood pressure and angina, chest pain caused by restriction of the blood flow to the heart. However, these drugs can have adverse effects in patients with heart failure... Read More
Previous Page Next Page